Amundi raised its position in UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) by 197.1% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 3,812 shares of the industrial products company's stock after purchasing an additional 2,529 shares during the period. Amundi's holdings in UFP Technologies were worth $957,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Illinois Municipal Retirement Fund lifted its stake in shares of UFP Technologies by 1.2% in the fourth quarter. Illinois Municipal Retirement Fund now owns 4,256 shares of the industrial products company's stock worth $1,041,000 after buying an additional 52 shares in the last quarter. Anchor Capital Advisors LLC raised its holdings in UFP Technologies by 1.5% in the 4th quarter. Anchor Capital Advisors LLC now owns 4,532 shares of the industrial products company's stock valued at $1,108,000 after acquiring an additional 69 shares during the last quarter. Los Angeles Capital Management LLC lifted its stake in UFP Technologies by 1.2% in the 4th quarter. Los Angeles Capital Management LLC now owns 5,870 shares of the industrial products company's stock worth $1,435,000 after purchasing an additional 70 shares in the last quarter. KBC Group NV boosted its holdings in shares of UFP Technologies by 42.4% during the 3rd quarter. KBC Group NV now owns 272 shares of the industrial products company's stock worth $86,000 after purchasing an additional 81 shares during the last quarter. Finally, Arete Wealth Advisors LLC grew its position in shares of UFP Technologies by 10.9% in the third quarter. Arete Wealth Advisors LLC now owns 909 shares of the industrial products company's stock valued at $287,000 after purchasing an additional 89 shares in the last quarter. Institutional investors and hedge funds own 87.28% of the company's stock.
Insiders Place Their Bets
In other news, Director Daniel C. Croteau sold 6,846 shares of the stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $228.41, for a total transaction of $1,563,694.86. Following the completion of the transaction, the director now directly owns 1,785 shares in the company, valued at approximately $407,711.85. This represents a 79.32 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 6.17% of the stock is owned by insiders.
UFP Technologies Trading Down 6.5 %
Shares of UFPT traded down $13.77 during mid-day trading on Friday, reaching $198.85. The stock had a trading volume of 175,222 shares, compared to its average volume of 74,937. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.57 and a quick ratio of 1.43. The business's fifty day moving average is $246.91 and its 200 day moving average is $277.62. UFP Technologies, Inc. has a 52-week low of $198.10 and a 52-week high of $366.41. The firm has a market cap of $1.53 billion, a price-to-earnings ratio of 28.37 and a beta of 1.15.
UFP Technologies (NASDAQ:UFPT - Get Free Report) last posted its quarterly earnings results on Tuesday, February 25th. The industrial products company reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.45. UFP Technologies had a net margin of 11.74% and a return on equity of 18.92%. The business had revenue of $144.07 million during the quarter, compared to analysts' expectations of $141.67 million.
Wall Street Analyst Weigh In
Separately, StockNews.com downgraded UFP Technologies from a "hold" rating to a "sell" rating in a research report on Thursday, January 23rd.
View Our Latest Stock Analysis on UFPT
UFP Technologies Company Profile
(
Free Report)
UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.
Read More

Before you consider UFP Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UFP Technologies wasn't on the list.
While UFP Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.